Login Register Cart 0
Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Evaluation of Cytotoxic Activity of Lavandula stoechas Aerial Parts Fractions against HepG2 Cell Lines

Author(s): Mohd. A. Siddiqui , Hefazat H. Siddiqui, Anuradha Mishra * and Afreen Usmani

Volume 16, Issue 9, 2020

Page: [1281 - 1289] Pages: 9

DOI: 10.2174/1573407215666190916102325

Price: $65

Abstract

Background: Lavandula stoechas is the main member of Labiatae (Lamiaceae) family. People use this medicinal plant in the treatment of several diseases around the world. The purpose of this work was to evaluate the cytotoxic effect of different fractions like ethanol, ethyl acetate and n-hexane from methanol extract of Lavandula stoechas aerial parts on HepG2 cell line and analysis of chemical composition of the most active fraction of the Lavandula stoechas aerial parts.

Methods: Methanolic extract was prepared by cold maceration. Fractions from extract were prepared in solvents of increasing polarity i.e. n-hexane, ethyl acetate and ethanol. In order to evaluate the cytotoxic effect of Lavandula stoechas, MTT assay method was used. For this purpose, HepG2 cells line were treated with the above mentioned Lavandula stoechas aerial parts fractions with different concentrations 10, 25, 50, 100, 250, 500 and 1000 μg/ml. The cells without treatment were served as a control.

Results: The result of this study showed that ethanolic fraction showed major reduction in % cell survival compared to other fractions. These results showed that Lavandula stoechas Ethanolic fraction was highly inhibitory. Further, phyto chemical analysis of ethanolic fraction was carried out using GC-MS technique and the reports showed Lupeol, Phytol, α-Cadinol, Lup-20(29)-en-3-one, hydrocoumarin, Lup-20(29)-en-3-one. Other compounds included fatty acids and their esters. Some of these compounds are being first time reported here from this plant.

Conclusion: MTT assay showed morphological changes, which clearly support Lavandula stoecha ethanolic fraction possesses anticancer effect which may be due to the presence of phytosterols.

Keywords: Lavandula stoechas, MTT assay, HepG2 cell line, GCMS analysis, cytotoxic effect, cirrhosis.

Graphical Abstract

[1]
Van den B.G. The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. J. Inherit. Metab. Dis., 1991, 14, 407-420.
[2]
Vernon, G.; Baranova, A.; Younossi, Z.M. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther., 2011, 34(3), 274-285.
[http://dx.doi.org/10.1111/j.1365-2036.2011.04724.x] [PMID: 21623852]
[3]
Gu, X.; Manautou, J.E. Molecular mechanisms underlying chemical liver injury. Expert Rev. Mol. Med., 2012, 14 e4.
[http://dx.doi.org/10.1017/S1462399411002110]
[4]
Seif, H.S.A. Physiological changes due to hepatotoxicity and the protective role of some medicinal plants. Beni-seuf Univ. J. Appl., 2016, 5(2), 134-146.
[5]
Adami, H.O.; Hunter, D.J.; Trichopoulos, D., Eds.; Textbook of cancer epidemiology; Oxford University Press: USA, 2008.
[http://dx.doi.org/10.1093/acprof:oso/9780195311174.001.0001]
[6]
de La Coste, A.; Romagnolo, B.; Billuart, P.; Renard, C.A.; Buendia, M.A.; Soubrane, O.; Fabre, M.; Chelly, J.; Beldjord, C.; Kahn, A.; Perret, C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA, 1998, 95(15), 8847-8851.
[http://dx.doi.org/10.1073/pnas.95.15.8847] [PMID: 9671767]
[7]
Balogh, J.; Victor, D., III; Asham, E.H.; Burroughs, S.G.; Boktour, M.; Saharia, A.; Li, X.; Ghobrial, R.M.; Monsour, H.P., Jr Hepatocellular carcinoma: A review. J. Hepatocell. Carcinoma, 2016, 3, 41-53.
[http://dx.doi.org/10.2147/JHC.S61146] [PMID: 27785449]
[8]
Waller, L.P.; Deshpande, V.; Pyrsopoulos, N. Hepatocellular carcinoma: A comprehensive review. World J. Hepatol., 2015, 7(26), 2648-2663.
[http://dx.doi.org/10.4254/wjh.v7.i26.2648] [PMID: 26609342]
[9]
Golabi, P.; Fazel, S.; Otgonsuren, M.; Sayiner, M.; Locklear, C.T.; Younossi, Z.M. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore), 2017, 96(9)e5904
[http://dx.doi.org/10.1097/MD.0000000000005904] [PMID: 28248853]
[10]
McGlynn, K.A.; London, W.T. The global epidemiology of hepatocellular carcinoma: Present and future. Clin. Liver Dis., 2011, 15(2), 223-243 vii-x..
[http://dx.doi.org/10.1016/j.cld.2011.03.006] [PMID: 21689610]
[11]
Venook, A.P.; Papandreou, C.; Furuse, J.; de Guevara, L.L. The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective. Oncologist, 2010, 15(4)(Suppl. 4), 5-13.
[http://dx.doi.org/10.1634/theoncologist.2010-S4-05] [PMID: 21115576]
[12]
Mittal, S.; El-Serag, H.B. Epidemiology of HCC: Consider the population. J. Clin.Gastroenterol. Hepatol., 2013, 47, S2-S6.
[13]
Bosetti, C.; Turati, F.; La Vecchia, C. Hepatocellular carcinoma epidemiology. Best Pract. Res. Clin. Gastroenterol., 2014, 28(5), 753-770.
[http://dx.doi.org/10.1016/j.bpg.2014.08.007] [PMID: 25260306]
[14]
Pinter, M.; Hucke, F.; Zielonke, N.; Trauner, M.; Sieghart, W.; Peck-Radosavljevic, M. Epidemiological trends of hepatocellular carcinoma in Austria. Dig. Dis., 2014, 32(6), 664-669.
[http://dx.doi.org/10.1159/000367983] [PMID: 25376282]
[15]
Petruzziello, A. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) related hepatocellular carcinoma. Open Virol. J., 2018, 12, 26-32.
[http://dx.doi.org/10.2174/1874357901812010026] [PMID: 29541276]
[16]
Schinzari, V.; Barnaba, V.; Piconese, S. Chronic hepatitis B virus and hepatitis C virus infections and cancer: Synergy between viral and host factors. Clin. Microbiol. Infect., 2015, 21(11), 969-974.
[http://dx.doi.org/10.1016/j.cmi.2015.06.026] [PMID: 26163104]
[17]
Bosch, F.X.; Ribes, J.; Cléries, R.; Díaz, M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis., 2005, 9(2), 191-211.
[http://dx.doi.org/10.1016/j.cld.2004.12.009] [PMID: 15831268]
[18]
Ghouri, Y.A.; Mian, I.; Rowe, J.H. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. J. Carcinog., 2017, 16(1), 1-3.
[http://dx.doi.org/10.4103/jcar.JCar_9_16] [PMID: 28694740]
[19]
Narayanan, P.; Ashraf, A.A.; Philip, A. Hepatocellular carcinoma profile in a tertiary care centre. Alcohol, 2017, 48, 57-14.
[20]
Kumar, V.; Abbas, A.K.; Fausto, N.; Robbins, S.L.; Cotran, R.S. Robbins and Cotran Pathologic Basis of Disease, 7th ed; Elsevier Saunders: Philadelphia, 2004.
[21]
Siddiqui, M.A.; Siddiqui, H.H.; Mishra, A.; Usmani, A. Epidemiology of hepatocellular carcinoma. Int. J. Pharm. Sci. Res., 2018, 9(12), 5050-5059.
[22]
Elbaz, T.; El Kassas, M.; Esmat, G. Management of hepatocellular carcinoma: Updated review. J. Can. Res. Ther., 2013, 4(2), 536-545.
[http://dx.doi.org/10.4236/jct.2013.42067]
[23]
Verma, S.; Thuluvath, P.J. Complementary and alternative medicine in hepatology: Review of the evidence of efficacy. Clin. Gastroenterol. Hepatol., 2007, 5(4), 408-416.
[http://dx.doi.org/10.1016/j.cgh.2006.10.014] [PMID: 17222587]
[24]
Thyagarajan, S.P.; Jayaram, S.; Gopalakrishnan, V.; Hari, R.; Jeyakumar, P.; Sripathi, M.S. Herbal medicines for liver diseases in India. J. Gastroenterol. Hepatol., 2002, 17(Suppl. 3), S370-S376.
[http://dx.doi.org/10.1046/j.1440-1746.17.s3.30.x] [PMID: 12472966]
[25]
Eskandani, M. BabakBahadori, M.; Zengin, G.; Dinparast, L.; Bahadori, S. Novel natural agents from Lamiaceae family: An evaluation on toxicity and enzyme inhibitory potential linked to diabetes mellitus. Curr. Bioact. Compd., 2016, 12(1), 34-38.
[http://dx.doi.org/10.2174/1573407212666151231183118]
[26]
Miraj, S. Lavandula stoechas L: A systematic review of medicinal and molecular perspectives. Der Pharm. Lett., 2016, 8(13), 56-58.
[27]
Siddiqui, M.A.; Khalid, M.; Akhtar, J. Siddiqui. H.H.; Badruddeen, Ahmad, U.; Ahsan, F.; Khan, M.M.; Ahmad, M.; Ali, A. Lavandula stoechas (Ustukhuddus): A miracle plant. J. Innov. Pharm. Biol. Sci., 2016, 3(1), 96-102.
[28]
Gören, A.; Topçu, G.; Bilsel, G.; Bilsel, M.; Aydoğmuş, Z.; Pezzuto, J.M. The chemical constituents and biological activity of essential oil of Lavandula stoechas ssp. stoechas. Z. Natforsch. C J. Biosci., 2002, 57(9-10), 797-800.
[http://dx.doi.org/10.1515/znc-2002-9-1007] [PMID: 12440714]
[29]
Bouyahya, A.; Dakka, N.; Lagrouh, F.; Abrini, J.; Bakri, Y. In vitro Antiproliferative and antidermatophyte activities of essential oils from three moroccan medicinal plants. J. Bio. Prod. Nat., 2018, 8(3), 144-153.
[30]
Malik, W.; Ahmed, D.; Izhar, S. Tyrosinase inhibitory activities of Carissa opacaStapf ex haines roots extracts and their phytochemical analysis. Pharmacogn. Mag., 2017, 13(3)(Suppl. 3), S544-S548.
[PMID: 29142412]
[31]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65(1-2), 55-63.
[http://dx.doi.org/10.1016/0022-1759(83)90303-4] [PMID: 6606682]
[32]
Philp, R.P. Biological markers in fossil fuel production. Mass Spectrom. Rev., 1985, 4(1), 1-54.
[http://dx.doi.org/10.1002/mas.1280040102]
[33]
Stanetic, D.; Buchbauer, G. Biological activity of some volatile diterpenoids. Curr. Bioact. Compd., 2015, 11(1), 38-48.
[http://dx.doi.org/10.2174/157340721101150804150419]
[34]
Zhang, L.; Tu, Y.; He, W.; Peng, Y.; Qiu, Z. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via brain-derived neurotrophic factor inhibition and glycogen synthase kinase 3 beta reactivation. Eur. J. Pharmacol., 2015, 762, 55-62.
[http://dx.doi.org/10.1016/j.ejphar.2015.05.030] [PMID: 26004524]
[35]
Kim, C.W.; Lee, H.J.; Jung, J.H.; Kim, Y.H.; Jung, D.B.; Sohn, E.J.; Lee, J.H.; Woo, H.J.; Baek, N.I.; Kim, Y.C.; Kim, S.H. Activation of Caspase-9/3 and inhibition of epithelial mesenchymal transition are critically involved in antitumor effect of phytol in hepatocellular car-cinoma cells. Phytother. Res., 2015, 29(7), 1026-1031.
[http://dx.doi.org/10.1002/ptr.5342] [PMID: 25892665]
[36]
Fadipe, V.O.; Mongalo, N.I.; Opoku, A.R. In vitro evaluation of the comprehensive antimicrobial and antioxidant properties of Curtisia dentata (Burm.f) C.A. Sm: Toxicological effect on the Human Embryonic Kidney (HEK293) and Human hepatocellular carcinoma (HepG2) cell lines. EXCLI J., 2015, 14, 971-983.
[PMID: 27065768]
[37]
Xiao, J.B.; Chen, X.Q.; Zhang, Y.W.; Jiang, X.Y.; Xu, M. Cytotoxicity of Marchantia convoluta leaf extracts to human liver and lung cancer cells. Braz. J. Med. Biol. Res., 2006, 39(6), 731-738.
[http://dx.doi.org/10.1590/S0100-879X2006000600005] [PMID: 16751978]

Rights & Permissions Print Cite
Article Metrics
10
© 2025 Bentham Science Publishers | Privacy Policy